Compare
Grindr Inc. vs Nebius Group N.V. vs Health Catalyst, Inc. vs Magnite, Inc.
| Latest fiscal year | Grindr Inc. GRND | Nebius Group N.V. NBIS | Health Catalyst, Inc. HCAT | Magnite, Inc. MGNI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $439.90M | $529.80M | $311.14M | $713.95M |
| Revenue growth (YoY) | +27.6% | +479.0% | +1.5% | +6.9% |
| Gross margin | n/a | 68.6% (computed) | n/a | 62.7% (computed) |
| Operating margin | 28.7% | -115.5% | -51.7% | 13.7% |
| Net margin | 21.5% | 15.6% | -57.2% | 20.3% |
| Net income | $94.75M | $82.50M | -$177.97M | $144.61M |
| EPS (Diluted) | $0.43 | $0.33 | -$2.55 | $0.95 |
| Operating cash flow | $141.52M | $401.90M | $731.0K | $236.17M |
| Free cash flow | $140.77M | -$3.66B | -$237.0K | $165.63M |
| Cash & equivalents | $87.05M | $3.68B | $50.81M | $553.36M |
| Total assets | $531.03M | $12.43B | $502.64M | $3.16B |
| Total liabilities | $484.02M | $7.84B | $256.86M | $2.24B |
| Shareholders' equity | $47.01M | $4.59B | $245.78M | $922.35M |
| Return on year-end equity | 201.6% | 1.8% | -72.4% | 15.7% |
| Shares outstanding | 185.03M | 253.02M | 72.03M | 142.96M |
Revenue, most recent five fiscal years
| Fiscal year | Grindr Inc. | Nebius Group N.V. | Health Catalyst, Inc. | Magnite, Inc. |
|---|---|---|---|---|
| Latest | $439.90M Ended 2025-12-31 | $529.80M Ended 2025-12-31 | $311.14M Ended 2025-12-31 | $713.95M Ended 2025-12-31 |
| 1 year earlier | $344.64M Ended 2024-12-31 | $91.50M Ended 2024-12-31 | $306.58M Ended 2024-12-31 | $668.17M Ended 2024-12-31 |
| 2 years earlier | $259.69M Ended 2023-12-31 | $9.80M Ended 2023-12-31 | $295.94M Ended 2023-12-31 | $619.71M Ended 2023-12-31 |
| 3 years earlier | $195.01M Ended 2022-12-31 | $13.50M Ended 2022-12-31 | $276.24M Ended 2022-12-31 | $577.07M Ended 2022-12-31 |
| 4 years earlier | $145.83M Ended 2021-12-31 | $4.79B Ended 2021-12-31 | $241.93M Ended 2021-12-31 | $468.41M Ended 2021-12-31 |